This article has multiple issues. Please help improve it or discuss these issues on the talk page. (Learn how and when to remove these template messages) This article provides insufficient context for those unfamiliar with the subject. Please help improve the article by providing more context for the reader. (April 2014) (Learn how and when to remove this template message) This article relies largely or entirely on a single source. Relevant discussion may be found on the talk page. Please help improve this article by introducing citations to additional sources.Find sources: "Rociverine" – news · newspapers · books · scholar · JSTOR (March 2021) (Learn how and when to remove this template message)
Rociverine
Clinical data
Other names(1S)-1-(diethylamino)propan-2-yl 1-hydroxybi(cyclohexane)-2-carboxylate
AHFS/Drugs.comInternational Drug Names
ATC code
Identifiers
  • 2-(diethylamino)-1-methylethyl (1S)-1-hydroxy-1,1'-bi(cyclohexyl)-2-carboxylate
CAS Number
PubChem CID
UNII
ECHA InfoCard100.053.356 Edit this at Wikidata
Chemical and physical data
FormulaC20H37NO3
Molar mass339.520 g·mol−1
  (verify)

Rociverine is an antimuscarinic drug.[1]

References

  1. ^ Toson G, Schiantarelli P, Murmann W (1978). "Rociverine, a new antispasmodic agent with balanced neurotropic and myotropic activity". Arzneimittel-Forschung. 28 (7): 1130–42. PMID 582702.